Abstract
OBJECTIVE--To quantify the effect of selection of relatively healthy women in studies reporting reduced relative risk for cardiovascular disease in postmenopausal women taking hormone replacement therapy. DESIGN--Review of the follow up studies reported in three recent meta-analyses to determine the effect of oestrogen therapy on both total cancer and cardiovascular disease. The same standard statistical methods as in the original analyses were used. MAIN OUTCOME MEASURES--Relative risks of total cancer and cardiovascular disease. RESULTS--In most of the follow up studies the relative risk for total cancer was below 1. The studies that showed the largest reduction in cardiovascular disease also showed the largest reduction in cancer, indicating a healthy cohort effect. Although heterogeneity within the studies prevented pooling, the best estimate for the protective effect on total cancer was a relative risk of 0.83 among women taking oestrogen (95% confidence interval 0.71 to 0.96), while in the same studies the relative risk for cardiovascular disease was 0.57 (0.50 to 0.64). CONCLUSIONS--Unintended selection of relatively healthy women for oestrogen therapy may have influenced the reported beneficial effect of oestrogen therapy on cardiovascular disease. It is unclear how much of the cardioprotection is due to this selection. Universal preventive hormonal replacement therapy for postmenopausal women is unwarranted at present.
Full text
PDF![1268](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7101/2540219/3aa3dc9bd8c8/bmj00440-0024.png)
![1269](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7101/2540219/1504fd2fa619/bmj00440-0025.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adami H. O. Long-term consequences of estrogen and estrogen-progestin replacement. Cancer Causes Control. 1992 Jan;3(1):83–90. doi: 10.1007/BF00051917. [DOI] [PubMed] [Google Scholar]
- Adami H. O., Persson I., Hoover R., Schairer C., Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer. 1989 Nov 15;44(5):833–839. doi: 10.1002/ijc.2910440515. [DOI] [PubMed] [Google Scholar]
- Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991 Sep 15;115(6):455–456. doi: 10.7326/0003-4819-115-6-455. [DOI] [PubMed] [Google Scholar]
- Burch J. C., Byrd B. F., Jr, Vaughn W. K. The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol. 1974 Mar 15;118(6):778–782. doi: 10.1016/0002-9378(74)90487-6. [DOI] [PubMed] [Google Scholar]
- Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
- Byrd B. F., Jr, Burch J. C., Vaughn W. K. The impact of long term estrogen support after hysterectomy. A report of 1016 cases. Ann Surg. 1977 May;185(5):574–580. doi: 10.1097/00000658-197705000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cauley J. A., Cummings S. R., Black D. M., Mascioli S. R., Seeley D. G. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1438–1444. doi: 10.1016/0002-9378(90)90602-4. [DOI] [PubMed] [Google Scholar]
- Colditz G. A., Stampfer M. J., Willett W. C., Hennekens C. H., Rosner B., Speizer F. E. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 1990 Nov 28;264(20):2648–2653. [PubMed] [Google Scholar]
- Criqui M. H., Suarez L., Barrett-Connor E., McPhillips J., Wingard D. L., Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol. 1988 Sep;128(3):606–614. doi: 10.1093/oxfordjournals.aje.a115008. [DOI] [PubMed] [Google Scholar]
- Falkeborn M., Persson I., Adami H. O., Bergström R., Eaker E., Lithell H., Mohsen R., Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992 Oct;99(10):821–828. doi: 10.1111/j.1471-0528.1992.tb14414.x. [DOI] [PubMed] [Google Scholar]
- Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet. 1981 Mar 7;1(8219):541–546. [PubMed] [Google Scholar]
- Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
- Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30. doi: 10.1093/oxfordjournals.epirev.a036298. [DOI] [PubMed] [Google Scholar]
- Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 1;133(5):525–536. doi: 10.1016/0002-9378(79)90288-6. [DOI] [PubMed] [Google Scholar]
- Henderson B. E., Paganini-Hill A., Ross R. K. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991 Jan;151(1):75–78. [PubMed] [Google Scholar]
- Hernandez Avila M., Walker A. M., Jick H. Use of replacement estrogens and the risk of myocardial infarction. Epidemiology. 1990 Mar;1(2):128–133. doi: 10.1097/00001648-199003000-00008. [DOI] [PubMed] [Google Scholar]
- Hunt K., Vessey M., McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol. 1990 Dec;97(12):1080–1086. doi: 10.1111/j.1471-0528.1990.tb02494.x. [DOI] [PubMed] [Google Scholar]
- Jacobs H. S., Loeffler F. E. Postmenopausal hormone replacement therapy. BMJ. 1992 Dec 5;305(6866):1403–1408. doi: 10.1136/bmj.305.6866.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kunst A. E., Looman C. W., Mackenbach J. P. Socio-economic mortality differences in The Netherlands in 1950-1984: a regional study of cause-specific mortality. Soc Sci Med. 1990;31(2):141–152. doi: 10.1016/0277-9536(90)90055-w. [DOI] [PubMed] [Google Scholar]
- Lafferty F. W., Helmuth D. O. Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects. Maturitas. 1985 Jul;7(2):147–159. doi: 10.1016/0378-5122(85)90021-0. [DOI] [PubMed] [Google Scholar]
- Marmot M. G., McDowall M. E. Mortality decline and widening social inequalities. Lancet. 1986 Aug 2;2(8501):274–276. doi: 10.1016/s0140-6736(86)92085-4. [DOI] [PubMed] [Google Scholar]
- Marmot M. G., Shipley M. J., Rose G. Inequalities in death--specific explanations of a general pattern? Lancet. 1984 May 5;1(8384):1003–1006. doi: 10.1016/s0140-6736(84)92337-7. [DOI] [PubMed] [Google Scholar]
- Meade T. W., Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992 Apr;48(2):276–308. doi: 10.1093/oxfordjournals.bmb.a072548. [DOI] [PubMed] [Google Scholar]
- Petitti D. B., Perlman J. A., Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol. 1987 Sep;70(3 Pt 1):289–293. [PubMed] [Google Scholar]
- Potocki J. Wpływ leczenia estrogenami na niewydolnoś wieńcowa u kobiet po menopauzie. Pol Tyg Lek. 1971 Nov 22;26(47):1812–1815. [PubMed] [Google Scholar]
- Shapiro S., Slone D., Rosenberg L., Kaufman D. W., Stolley P. D., Miettinen O. S. Oral-contraceptive use in relation to myocardial infarction. Lancet. 1979 Apr 7;1(8119):743–747. doi: 10.1016/s0140-6736(79)91205-4. [DOI] [PubMed] [Google Scholar]
- Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
- Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
- Sullivan J. M., Vander Zwaag R., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med. 1990 Dec;150(12):2557–2562. [PubMed] [Google Scholar]
- Vandenbroucke J. P. Postmenopausal oestrogen and cardioprotection. Lancet. 1991 Apr 6;337(8745):833–834. doi: 10.1016/0140-6736(91)92526-8. [DOI] [PubMed] [Google Scholar]
- Wilson P. W., Garrison R. J., Castelli W. P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985 Oct 24;313(17):1038–1043. doi: 10.1056/NEJM198510243131702. [DOI] [PubMed] [Google Scholar]
- Wolf P. H., Madans J. H., Finucane F. F., Higgins M., Kleinman J. C. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol. 1991 Feb;164(2):489–494. doi: 10.1016/s0002-9378(11)80006-2. [DOI] [PubMed] [Google Scholar]